Skip to search.
 TSX Up 0.17% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Geron Corporation (GERN)

-NasdaqGS
2.04 Up 0.04(1.75%) 10:57AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:2.00
Open:2.07
Bid:2.02 x 7300
Ask:2.03 x 6500
1y Target Est:2.00
Beta:2.46
Earnings Date:Apr 28 - May 2 (Est.)
Day's Range:1.95 - 2.12
52wk Range:1.05 - 7.79
Volume:1,365,055
Avg Vol (3m):6,356,870
Market Cap:319.29M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Must Read

Comparison

Symbol% ChgMkt Cap
GERNUp 1.75%319.29M
BMYDown 0.34%83.79B
GSKUp 0.40%132.62B
NVSDown 2.24%204.37B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):244.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.25
Quarterly EPS Est (Mar-14) :-0.06
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):-1.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback